• Q1 2021 Revenue of $23.8 million
• Planet 13 accounted for 8.6% of all Nevada cannabis dispensary revenue in Q1
• Q1 2021 EBITDA of $5.2 million

All figures are reported in United States dollars ($) unless otherwise indicated

LAS VEGAS, NV / ACCESSWIRE / May 27, 2021 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQB:PLNHF) ("Planet 13" or the "Company"), a leading vertically-integrated Nevada cannabis company, today announced its financial results for the three-month period ended March 31, 2021. Planet 13's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

"After a slower January and February, due to COVID-19 related restrictions in place in Nevada, we had an absolutely outstanding March, April, and now May. It is clear that Vegas is back, and with hotels and casinos across the strip reporting being fully booked for the foreseeable future we think it's just getting started," said Larry Scheffler, Co-CEO of Planet 13. "After a year of fighting against the largest possible macro storm, it feels great to have the wind at our backs and to see all the improvements we put in place start to pay off."

"Tourism is back, and the SuperStore is performing well. The Medizin store is proving that our blend of entertainment, customer service, and product selection work in smaller footprint retail stores. Our wholesale is growing at a solid pace. Across our Nevada operations, we are experiencing a successful return to growth," commented Bob Groesbeck, Co-CEO of Planet 13. "In California, we are on track and on budget for our Orange County SuperStore - P13 OC. We've taken everything we've learned running the Las Vegas SuperStore and put it into this Store. We are set to open in July, and we look forward to bringing the Planet 13 experience to California and introducing it to millions of first time visitors."

Financial Highlights - Q1 - 2021

Operating Results

All comparisons below are to the quarter ended March 31, 2020, unless otherwise noted

• Revenues were $23.8 million as compared to $16.8 million, an increase of 41.8%
• Gross profit before biological adjustments was $12.8 million or 53.8% as compared to $9.0 million or 53.9%
• Operating expenses, excluding non-cash compensation expense and depreciation and amortization, was $8.4 million as compared to $7.0 million, an increase of 21.0%
• Net income before taxes of $3.0 million as compared to a net income of $0.3 million
• Net income of $0.4 million as compared to a net loss of $1.4 million
• Adjusted EBITDA of $5.2 million as compared to Adjusted EBITDA of $2.4 million

Balance Sheet

All comparisons below are to December 31, 2020, unless otherwise noted

• Cash of $141.1 million as compared to $79.0 million
• Total assets of $218.4 million as compared to $150.0 million
• Total liabilities of $35.0 million as compared to $29.3 million

Q1 Highlights and Recent Developments

For a more comprehensive overview of these highlights and recent developments, please refer to Planet 13's Management's Discussion and Analysis of the Financial Condition and Results of Operations for the Three Months Ended March 31, 2021 (the "MD&A").

• On February 2, 2021, Planet 13 announced closing of CDN$69 million bought deal, upsized from CDN$50 million.
• On February 3, 2021, Planet 13 announced the start of construction on the Orange County SuperStore.
• On March 15, 2021 Planet 13 announced a partnership with Curaleaf Select to open shop-in-shop.
• On April 19, 2021 Planet 13 announced the grant of restricted stock units.
• On April 22, 2021 Planet 13 announced record sales on "420."
• On May 10, 2021 Planet 13 announced the conversion of all Class A restricted shares to common shares.

Results of Operations (Summary)

The following tables set forth consolidated statements of financial information for the three-month periods ending March 31, 2021 and March 31, 2020. For further information regarding the Company's financial results for these periods, please refer to the Company's annual financial statements for the period ended March 31, 2021 together with the MD&A, available on Planet 13's issuer profile on SEDAR at www.sedar.com and the Company's website https://www.planet13holdings.com.

Adjusted EBITDA

		NV Cannabis Ops				Consolidated				Consolidated
		Three Months				Three Months				Three Months
		Ended				Ended				Ended
		Mar-31-2021				Mar-31-2021				Mar-31-2020
EBITDA
Profit (loss) before taxes			4,356,088				3,047,835				304,497
Add back:
Biological asset adjustments			(366,746	)			(366,746	)			(234,419	)
Non-cash share based payments			-				203,973				810,823
Depreciation and amortization			1,083,122				1,083,122				987,008
Depreciation included in COGS			517,177				517,177				157,026
ROU Interest included in COGS			325,718				325,718				35,524
Interest and non-operating expense (income)			407,966				407,966				329,291
EBITDA			6,323,325				5,219,045				2,389,750
Margin			26.6	%			21.9	%			14.2	%

 

Expressed in USD$		Three Months				Three Months
		Ended				Ended				Percentage
		Mar-31-2021				Mar-31-2020				Change
Revenue
Revenues, net of discounts			23,816,208				16,793,002				41.8	%
Cost of Goods Sold			(11,006,530	)			(7,746,922	)			42.1	%
Gross Profit, Before Biological Asset Adjustment			12,809,678				9,046,080				41.6	%
Gross Profit Margin %			53.8	%			53.9	%
Realized fair value amounts included in COGS			(288,476	)			(193,196	)			49.3	%
Unrealized fair value gain on growth of biological assets			655,222				427,615				53.2	%
Gross profit			13,176,424				9,280,499				42.0	%
Gross Profit Margin %			55.3	%			55.3	%
Expenses
General and Administrative			7,773,579				5,522,514				40.8	%
Sales and Marketing			659,949				1,446,608				(54.4	%)
Depreciation and Amortization			1,083,122				987,008				9.7	%
Share based payments			203,973				810,823				(74.8	%)
Total Expenses			9,720,623				8,766,953				10.9	%
Income (Loss) From Operations			3,455,801				513,546				572.9	%
Other (Income) Expense:
Interest Expense, net			470,863				281,005				67.6	%
Realized Foreign Exchange gain (loss)			-				-			na
Other expense (income)			(62,897	)			(71,956	)			(12.6	%)
Total Other (Income) Expense			407,966				209,049				95.2	%
Income (loss) for the period before tax			3,047,835				304,497				900.9	%
Provision for income tax (current and deferred)			2,605,072				1,713,559				52.0	%
Income (Loss) for the period			442,763				(1,409,062)				(131.4	%)
Other Comprehensive Income (Loss)
Items that may be reclassified subsequently to profit/loss
Foreign exchange translation adjustment			829,635				31,069
Net Comprehensive Income (Loss) for the period			1,272,398				(1,377,993)
Income (Loss) per share for the period
Basic and fully diluted income (loss) per share		$	0.00			$	(0.01)
Weighted Average Number of Shares Outstanding
Basic			190,777,592				138,915,955
Diluted			193,050,462				138,915,955

Outstanding Shares

As of May 26, 2021, the Company had 196,386,104 common shares outstanding. There were 184,168 options issued and outstanding of which 176,669 have fully vested. There were 8,877,751 warrants outstanding and 4,994,567 RSU's outstanding of which nil RSUs had fully vested as at the date of this MD&A.

Conference Call

Planet 13 will host a conference call on Thursday, May 27, 2021 at 5:00 p.m. ET to discuss its first quarter financial results and provide investors with key business highlights. The call will be chaired by Bob Groesbeck, Co-CEO, Larry Scheffler, Co-CEO, and Dennis Logan, CFO.

CONFERENCE CALL DETAILS

Date: May 27, 2021 | Time: 5:00 p.m. EST

Participant Dial-in: Toll Free 877-407-8035 or International 201-689-8035

Replay Dial-in: Toll Free 877-481-4010 or International 919-882-2331

(Available for 2 weeks)

Reference Number: 41412

Listen to webcast: https://bit.ly/3or4jFC

Financial Measures

There are measures included in this news release that do not have a standardized meaning under generally accepted accounting principles (GAAP) and therefore may not be comparable to similarly titled measures and metrics presented by other publicly traded companies. The Company includes these measures because it believes certain investors use these measures and metrics as a means of assessing financial performance. EBITDA (earnings before interest, taxes, depreciation and amortization) is calculated as net earnings before finance costs (net of finance income), income tax expense, and depreciation and amortization of intangibles and is a non-GAAP financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies.

For further inquiries, please contact:

LodeRock Advisors Inc., Planet 13 Investor Relations
mark.kuindersma@loderockadvisors.com
(416) 519-2156 ext. 2230

Bob Groesbeck and Larry Scheffler
Co-Chief Executive Officers
ir@planet13lasvegas.com

About Planet 13

Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas - the entertainment capital of the world. Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13's shares trade on the Canadian Stock Exchange (CSE) under the symbol PLTH and OTCQX under the symbol PLNHF.

Cautionary Note Regarding Forward-Looking Information

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking-statements relate to, among other things, Planet 13's first California location and the timeline for opening of the Santa Ana dispensary.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: final regulatory and other approvals or consents; risks associated with COVID-19 and other infectious diseases presenting as major health issues; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Nevada and California cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in the State of Nevada and California; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States through licensed subsidiary entities in states that have legalized marijuana operations, however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business, including COVID-19, are contained under the heading "Risk Factors" and elsewhere in the Company's annual information form dated April 5, 2021 filed on its issuer profile on SEDAR at www.sedar.com.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Expressed in United States Dollars		As at				As at
		March 31,				December 31,
		2021				2020
Assets
Current Assets
Cash		$	141,126,157			$	79,000,850
HST receivable			132,636				103,445
Inventories (Note 5)			9,099,432				7,334,717
Biological assets (Note 6)			920,975				640,995
Prepaid expenses and other current assets (Note 10)			5,057,135				2,637,547
Total Current Assets			156,336,335				89,717,554
Property and equipment (Note 7)			34,149,653				32,073,925
Licenses (Note 8)			7,007,362				7,007,362
Right of use assets (Note 9)			19,894,552				20,149,721
Long-term deposits and other assets			1,054,443				1,054,443
			62,106,010				60,285,451
Total Assets		$	218,442,345			$	150,003,005
Liabilities
Current Liabilities
Accounts payable		$	3,293,068			$	1,683,833
Accrued expenses			4,273,664				2,844,714
Income taxes payable			3,716,909				1,220,652
Notes payable - current portion (Note 11)			884,000				884,000
Total Current Liabilities			12,167,641				6,633,199
Long -term lease liabilities (Note 12)			22,404,495				22,326,077
Other long-term liabilities			28,000				28,000
Deferred tax liability			422,237				313,422
			22,854,732				22,667,499
Total Liabilities			35,022,373				29,300,698
Shareholders' Equity
Share capital (Note 13)			196,957,891				139,177,034
Restricted share units (Note 13)			1,714,792				3,262,351
Warrants (Note 13)			12,255,137				6,972,053
Option reserve (Note 13)			204,966				276,081
Accumulated other comprehensive loss			350,513				(479,122	)
Deficit			(28,063,327	)			(28,506,090	)
Total Shareholders' Equity			183,419,972				120,702,307
Total Liabilities and Shareholders' Equity		$	218,442,345			$	150,003,005

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND
COMPREHENSIVE INCOME (LOSS)

Expressed in United States Dollars		Three months				Three months
		Ended				Ended
		March 31,				March 31,
		2021				2020
Revenue
Revenues, net of discounts		$	23,816,208			$	16,793,002
Cost of Goods Sold			(11,006,530	)			(7,746,922	)
Gross Profit before fair value asset adjustment			12,809,678				9,046,080
Realized fair value amounts included in inventory sold			(288,476	)			(193,196	)
Unrealized fair value gain on growth of biological assets			655,222				427,615
Gross Profit			13,176,424				9,280,499
Expenses
General and Administrative (Note 12 and Note 14)			7,773,579				5,522,514
Sales and Marketing			659,949				1,446,608
Depreciation and Amortization (Note 7 & 9)			1,083,122				987,008
Share-Based Compensation Expense (Note 13 and Note 17)			203,973				810,823
Total Expenses			9,720,623				8,766,953
Other Expense:
Interest expense, net			470,863				281,005
Other income			(62,897	)			(71,956	)
Total Other Expense			407,966				209,049
Income before income taxes			3,047,835				304,497
Provision for tax - current			2,496,257				1,853,382
Provision for tax - deferred			108,815				(139,823	)
Income (loss) for the period		$	442,763			$	(1,409,062)
Other Comprehensive Income
Foreign exchange translation gain			829,635				31,069
Net Comprehensive Income (Loss) for the period		$	1,272,398			$	(1,377,993)
Net income (loss) per share for the period
Basic and diluted income (loss) per share (Note 16)		$	0.00			$	(0.01)
Weighted Average Number of Common Shares Outstanding
Basic			190,777,592				138,915,955
Diluted			193,050,462				138,915,955

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Expressed in United States Dollars		Three Months				Three Months
		Ended				Ended
		March 31,				March 31,
		2021				2020
Operating activities
Net income (loss) for the period		$	442,763			$	(1,409,062	)
Add (deduct) non-cash items:
Share based payments (Note 13 and 17)			203,973				810,823
Depreciation and amortization (Note 7 and 9)			1,651,389				1,400,265
Deferred tax liability			108,815				(171,041	)
Other assets			-				(1,317,580	)
Non-cash accretion of lease liabilities (Note 12)			367,337				-
Non-cash interest expense on ROU Liabilities (Note 12)			470,863				400,836
Net change in non-cash working capital
HST receivable			(30,505	)			(8,112	)
Inventories (Note 5)			(1,764,715	)			(1,151,096	)
Biological assets (Note 6)			(279,980	)			(125,294	)
Prepaid expenses and other assets (Note 10)			(2,421,189	)			788,819
Accounts payable			1,609,684				1,206,528
Accrued expenses			1,428,951				133,728
Income tax payable			2,496,257				1,884,600
Cash flow provided by operating activities			4,283,643				2,443,414
Investing activities
Purchase of property and equipment (Note 7)			(3,471,948	)			(2,086,591	)
Cash flow used in investing activities			(3,471,948)				(2,086,591)
Financing activities
Issuance of shares on warrant and option exercises (Note 13)			10,884,762				1,064,521
Issuance of shares and warrants on financings (Note 13)			50,356,532				-
Payment on lease liabilities (Note 12)			(759,782	)			(329,245	)
Cash flow provided by financing activities			60,481,512				735,276
Net increase in cash			61,293,207				1,092,099
Cash at beginning of the year			79,000,850				12,814,712
Effect of foreign exchange on cash			832,100				31,069
Cash at end of the period		$	141,126,157			$	13,937,880

1 Market share data is based on January and February results https://tax.nv.gov/uploadedFiles/taxnvgov/Content/TaxLibrary/NV-Marijuana-Revenue-FY21(4).pdf

View source version on accesswire.com:
https://www.accesswire.com/649439/Planet-13-Announces-Q1-2021-Financial-Results